The ER expression in EEC-AIA has been described in a few reports, which documented surprisingly low ER expression (14.3% compared with 84.6% in other endometrial cancer in Matsuo et al. 14 and versus 93.4% in Machida et al. 11). This evidence concerns the gene ESR1 and endometrial cancer.